Special Issue "Immunomodulatory Compounds"
Deadline for manuscript submissions: closed (30 September 2018)
Nature has developed, during evolution, a broad variety of immunomodulatory compounds, e.g., to facilitate invasion and/or persistence of pathogens and parasites. The characterization of these compounds have provided new insights into immunology, parasitology and various diseases, such as autoimmune diseases. The development of chemical analogues of these naturally-occurring compounds has opened a new field of drug development and medical therapy.
The scope of this Special Issue is to give an overview of this field, comprising the detection and characterization of naturally-occurring immunomodulatory compounds, their application in medicine and veterinary medicine, and the development of chemical analogues and their therapeutic perspectives.
Prof. Dr. Günter Lochnit
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- autoimmune diseases
- hepatic targeting